Apimeds Pharmaceuticals US, Inc.
APUS
$71M
Market cap
$71M
Stock Price
$3.54+$1.87 (+112.61%)
Sep 1, 2026
52W High $8.0052W Low $0.71
Company Details
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company is based in Ras al-Khaimah, the United Arab Emirates. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of In...
IPO Date
May 9, 2025
Website
www.mindwavedao.comKey Metrics TTM
Revenue
$0
- YoY
Net Income
-$5M
EPS (Diluted)
-
Free Cash Flow
-$5M
Revenue / Share
$0.00
Gross Margin
-
Operating Margin
-
Net Margin
-
FCF Margin
-
P/S
-
P/E
-
Quarterly reports
Revenue & Profitability
Operating Cash Flow
CapEx Spend
CapEx Spend
OpEx vs Revenue Growth (YoY)
Stock-Based Compensation
OpEx Breakdown
War Chest
Shares Outstanding
Shares Outstanding
Revenue Per Employee
Revenue / Employee